good product potential and yet very low SP response here...I think MSB just needs to get FDA approval and everything will be up again...I am still holding on my old shares and plan to top up some more at this price when funds come in...
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-44
-
- There are more pages in this discussion • 380 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
0.000(0.00%) |
Mkt cap ! $1.318B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.20 | $1.15 | $2.939M | 2.516M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 29 | 56860 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 35858 | 9 |
View Market Depth
| Last trade - 14.09pm 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |